Pharmaceutical company Eli Lilly and Company—or Lilly—announced its plans to build a $6.5 billion manufacturing facility at Generation Park at a news conference Sept. 23.

Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more ...

The list prices of obesity drugs Wegovy and Zepbound are over $1,000, but that's not necessarily what you pay.

Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on ...

"The White House Medical Unit quickly jumped into action, and the gentleman is okay," White House press secretary Karoline Leavitt said.

According to the White House, Novo Nordisk's semaglutide-based Ozempic for diabetes and Wegovy for obesity will cost $350 per ...

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly.

A deal with Lilly and Novo would be significant for the administration’s push for lower drug prices for Americans.